Literature DB >> 8189529

Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.

N M Mattion1, P A Reilly, S J DiMichele, J C Crowley, C Weeks-Levy.   

Abstract

The ability to express heterologous antigens from attenuated poliovirus strains suggests the potential for use as live vectored vaccines. Full- or partial-length sequences of the gene encoding rotavirus major outer capsid protein VP7 were cloned into the open reading frame of a full-length cDNA copy of poliovirus Sabin type 3. They were inserted either at the 5' end or immediately after the capsid protein coding region, at the junction between precursors P1 and P2. A protease cleavage site for 3C protease was introduced 3' to the foreign sequences to enable proteolytic processing of the antigen from the poliovirus polyprotein. Infectious viruses were generated from several of the DNA constructs, and the presence of the foreign gene sequences was confirmed by reverse transcription of the viral RNA and PCR amplification. Viruses with inserts of about 300 bases maintained the foreign sequences during passage in Vero cells. Viruses carrying larger sequences were unstable, and deletions were generated within the foreign sequences. Expression of the VP7 polypeptides was demonstrated by immunoprecipitation with specific antiserum of labeled proteins from cells infected with Sabin 3 recombinant viruses. Comparative studies of RNA synthesis showed similar kinetics for Sabin 3 and the Sabin 3/VP7 recombinants. One-step growth curves showed that production of recombinant viruses was slower than that of Sabin 3 and that the final titers were 1 to 1.5 logs lower. Accumulation of VP7-containing precursors in infected cells suggests that slow cleavage at the engineered 3C protease site may be a limiting step in the growth of these recombinant Sabin polioviruses and may influence the permissible size of foreign sequence to be inserted.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189529      PMCID: PMC236898     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Processing of rotavirus glycoprotein VP7: implications for the retention of the protein in the endoplasmic reticulum.

Authors:  S C Stirzaker; P L Whitfeld; D L Christie; A R Bellamy; G W Both
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

2.  Expression of bovine rotavirus neutralization antigen in Escherichia coli.

Authors:  M Francavilla; P Miranda; A Di Matteo; A Sarasini; G Gerna; G Milanesi
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

3.  Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein.

Authors:  M Sabara; J E Gilchrist; G R Hudson; L A Babiuk
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Antigen chimaeras of poliovirus as potential new vaccines.

Authors:  K L Burke; G Dunn; M Ferguson; P D Minor; J W Almond
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

6.  An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide.

Authors:  M A Franco; I Prieto; M Labbé; D Poncet; F Borras-Cuesta; J Cohen
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

7.  Synthesis of the outer-capsid glycoprotein of the simian rotavirus SA11 in Escherichia coli.

Authors:  C F Arias; T Ballado; M Plebañski
Journal:  Gene       Date:  1986       Impact factor: 3.688

8.  Expression of a major bovine rotavirus neutralisation antigen (VP7c) in Escherichia coli.

Authors:  M A McCrae; J G McCorquodale
Journal:  Gene       Date:  1987       Impact factor: 3.688

9.  A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.

Authors:  H Toyoda; M J Nicklin; M G Murray; C W Anderson; J J Dunn; F W Studier; E Wimmer
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.

Authors:  D C Porter; D C Ansardi; W S Choi; C D Morrow
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  29 in total

1.  Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Authors:  N M Chapman; K S Kim; S Tracy; J Jackson; K Höfling; J S Leser; J Malone; P Kolbeck
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity.

Authors:  S Tang; R van Rij; D Silvera; R Andino
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Viable polioviruses that encode 2A proteins with fluorescent protein tags.

Authors:  Natalya L Teterina; Eric A Levenson; Ellie Ehrenfeld
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

4.  Expression of brain-derived neurotrophic factor in the central nervous system of mice using a poliovirus-based vector.

Authors:  Qingmei Jia; Fengyi Liang; Seii Ohka; Akio Nomoto; Tsutomu Hashikawa
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

5.  Expression of an antigenic adenovirus epitope in a group B coxsackievirus.

Authors:  K Höfling; S Tracy; N Chapman; K S Kim; J Smith Leser
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA.

Authors:  K L McKnight; S M Lemon
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 8.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

9.  Theiler's virus as a vector for foreign gene delivery.

Authors:  L Zhang; S Sato; J I Kim; R P Roos
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.

Authors:  D C Porter; L R Melsen; R W Compans; C D Morrow
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.